Apimeds Pharmaceuticals US Inc. (APUS)
NYSE: APUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
APUS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $10.64M
- EPS (TTM)
- -$36.03
- Dividend yield
- None
- 52-week range
- 1.51 – 59.70
- Day range
- 6.86 – 9.84
- Volume / Avg
- 22.33M / 3.36M
- Beta
- —
- Shares outstanding
- 1.51M
52-week range
APUS stock today
On Oct 7, APUS ended the session at $7.05, shedding $0.08 (1.12%), versus the S&P 500's 0.22% decline. Volume was 6.6x the average at 22.33M shares, a sign of unusually heavy trading. Shares are 88.2% below their 52-week high of $59.70, set on May 5, 2026 and 366.9% above the 52-week low of $1.51, near the bottom of the past year's range.
APUS is down 57.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 58.8%. Apimeds Pharmaceuticals US has posted a net loss over the last twelve months (EPS of -$36.03), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Apimeds Pharmaceuticals US
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2025
Apimeds Pharmaceuticals US peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TOVXTheriva Biologics Inc. | 0.234 | +5.41% | $10.74M | vs APUS |
| ADILAdial Pharmaceuticals Inc | 3.99 | +0.25% | $10.48M | vs APUS |
| VTGNVistagen Therapeutics Inc. | 0.2471 | -1.40% | $10.97M | vs APUS |
| BLRXBioLineRx Ltd. ADR | 2.21 | -3.80% | $10.98M | vs APUS |
| CALCCalciMedica Inc. | 1.48 | 0.00% | $10.11M | vs APUS |
| GTBPGT Biopharma Inc. | 6.20 | -2.67% | $11.19M | vs APUS |
| KPRXKiora Pharmaceuticals Inc. | 2.53 | +1.20% | $11.19M | vs APUS |
| CMMBChemomab Therapeutics Ltd. ADR | 1.37 | -2.14% | $10.04M | vs APUS |
Indexes, lists and sector
Apimeds Pharmaceuticals US stock FAQ
What is Apimeds Pharmaceuticals US's stock price today?
APUS last traded at $7.05 as of Oct 7, 4:00 PM EDT, down 1.12% on the day. Prices are delayed at least 15 minutes.
Does Apimeds Pharmaceuticals US pay a dividend?
No. Apimeds Pharmaceuticals US does not currently pay a regular cash dividend.
Has APUS ever split its stock?
Yes. The most recent APUS stock split was a 1-for-10 split on Jul 24, 2026.
What is the APUS 52-week high?
The 52-week high for APUS is $59.70 and the 52-week low is $1.51. The stock is currently 88.2% below its high.